-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SRyQgRuvoMMV0XU7a8GYGsdFsqzBZ2OBIl6mYmfl0gW79lA3c4rk101R8++V7bEL nkilRttqG8oJR40kliqDpA== 0000935836-98-000096.txt : 19980427 0000935836-98-000096.hdr.sgml : 19980427 ACCESSION NUMBER: 0000935836-98-000096 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980424 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DUSA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000879993 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223103129 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-42248 FILM NUMBER: 98600908 BUSINESS ADDRESS: STREET 1: 181 UNIVERSITY AVE, STE 1208 STREET 2: TORONTO, ONTARIO, CITY: CANADA M5H 3M7 STATE: A6 BUSINESS PHONE: 4163635059 MAIL ADDRESS: STREET 1: 181 UNIVERSITY AVE STE 1208 STREET 2: TORONTO ONTARIO M5H 3M7 CITY: CANADA STATE: A6 FORMER COMPANY: FORMER CONFORMED NAME: DEPRENYL USA INC / NJ DATE OF NAME CHANGE: 19930328 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BULLDOG CAPITAL MANAGEMENT LP /ADV CENTRAL INDEX KEY: 0001017498 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 593349779 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 33 N GARDEN AVE STREET 2: STE 750 CITY: CLEARWATER STATE: FL ZIP: 33755 BUSINESS PHONE: 8132985400 MAIL ADDRESS: STREET 1: 33 N GARDEN AVENUE STREET 2: SUITE 750 CITY: CLEARWATER STATE: FL ZIP: 33755 FORMER COMPANY: FORMER CONFORMED NAME: BULLDOG CAPITAL MANAGEMENT LP /ADV DATE OF NAME CHANGE: 19960913 SC 13G 1 OMB APPROVAL OMB Number:3235-0145 Expires: August 31, 1999 Estimated average burden hours per form 14.90 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) DUSA Pharmaceuticals, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 266898105 (CUSIP Number) * (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / X / Rule 13d-1(b) /___/ Rule 13d-1(c) /___/ Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1745 (3-98) Page 1 of 10 CUSIP No. 266898105 - ---------------------------------------------------------------- 1 NAME OF REPORTING PERSON IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Bulldog Capital Management Limited Partnership - ---------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) / / (b) / / - ---------------------------------------------------------------- 3 SEC USE ONLY - ---------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ---------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES 671,200 BENEFICIALLY --------------------------------------- OWNED BY 6 SHARED VOTING POWER EACH -0- REPORTING --------------------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH 671,200 --------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - ---------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 671,200 - ---------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) - ---------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 7.2 - ---------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (See Instructions) PN and IA - ---------------------------------------------------------------- Page 2 of 10 CUSIP No. 266898105 - ---------------------------------------------------------------- 1 NAME OF REPORTING PERSON IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Bulldog Capital Management, Inc. - ---------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) / / (b) / / - ---------------------------------------------------------------- 3 SEC USE ONLY - ---------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Florida - ---------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES -0- BENEFICIALLY --------------------------------------- OWNED BY 6 SHARED VOTING POWER EACH 671,200 REPORTING --------------------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH -0- --------------------------------------- 8 SHARED DISPOSITIVE POWER 671,200 - ---------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 671,200 - ---------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) - ---------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 7.2 - ---------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (See Instructions) CO - ---------------------------------------------------------------- Page 3 of 10 CUSIP No. 266898105 - ---------------------------------------------------------------- 1 NAME OF REPORTING PERSON IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Ronald J. Pollack - ---------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) / / (b) / / - ---------------------------------------------------------------- 3 SEC USE ONLY - ---------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - ---------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES -0- BENEFICIALLY --------------------------------------- OWNED BY 6 SHARED VOTING POWER EACH 671,200 REPORTING --------------------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH -0- --------------------------------------- 8 SHARED DISPOSITIVE POWER 671,200 - ---------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 671,200 - ---------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) - ---------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 7.2 - ---------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (See Instructions) IN - ---------------------------------------------------------------- Page 4 of 10 CUSIP No. 266898105 ITEM 1. (a) The name of the issuer is DUSA Pharmaceuticals, Inc. ("DUSA"). (b) The principal executive office of DUSA is located at 181 University Avenue, Suite 1208, Toronto, Ontario, CANADA. ITEM 2. The persons filing this statement are as follows: (a) Bulldog Capital Management Limited Partnership, a Delaware limited partnership ("BCM, L.P."), Bulldog Capital Management, Inc., a Florida corporation ("BCM, Inc."), and Ronald J. Pollack ("Pollack"). BCM, Inc., is the general partner of BCM, L.P. Pollack is the controlling shareholder of BCM, Inc. Pollack, Mireille Pollack ("M. Pollack"), and Brandon L. Marion ("Marion"), are the directors of BCM, Inc. Marion is the President and Treasurer of BCM, Inc. M. Pollack is the Secretary of BCM, Inc. (b) The business address of BCM, L.P., BCM, Inc., Pollack, M. Pollack, and Marion, is 33 Garden Avenue North, Suite 750, Clearwater, Florida, 34615. (c) Pollack, M. Pollack, and Marion are citizens of the United States. (d) This statement relates to shares of Common Stock of DUSA (the "Stock"). (e) The CUSIP number of the Stock is 266898105. Page 5 of 10 CUSIP No. 266898105 ITEM 3. If this statement is filed pursuant to rule 240.13d- 1(b), or 240.13d-2(b) or (c), check whether the person filing is a: (a) ___ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) ___ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) ___ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) ___ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) _X__ An investment adviser in accordance with 240.13d- 1(b)(1)(ii)(E). (f) ___ An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F). (g) ___ A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G) (h) ___ A savings association as defined in section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) ___ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). (j) ___ Group, in accordance with section 240.13d- 1(b)(1)(ii)(J) Page 6 of 10 CUSIP No. 266898105 ITEM 4. OWNERSHIP. The beneficial ownership of the Stock of the persons named in Item 2 of this statement is as follows at the date hereof: BCM, L.P. (a) Amount beneficially owned: 671,200. (b) Percent of class: 7.2. (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 671,200. (ii) Shared power to vote or to direct the vote -0-. (iii) Sole power to dispose or to direct the disposition of 671,200. (iv) Shared power to dispose or to direct the disposition of -0-. BCM, Inc. (a) Amount beneficially owned: 671,200. (b) Percent of class: 7.2. (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote -0-. (ii) Shared power to vote or to direct the vote 671,200. (iii) Sole power to dispose or to direct the disposition of -0-. (iv) Shared power to dispose or to direct the disposition of 671,200. Page 7 of 10 CUSIP No. 266898105 Pollack (a) Amount beneficially owned: 671,200. (b) Percent of class: 7.2. (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote -0-. (ii) Shared power to vote or to direct the vote 671,200. (iii) Sole power to dispose or to direct the disposition of -0-. (iv) Shared power to dispose or to direct the disposition of 671,200. Page 8 of 10 CUSIP No. 266898105 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following /___/. ITEM. 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON BCM, L.P., is a registered investment adviser whose clients have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Stock. No individual client's holdings of the Stock are more than 5 percent of the class. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not applicable. Page 9 of 10 CUSIP No. 266898105 ITEM 10. CERTIFICATION By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURES DATED: April 23, 1998 BULLDOG CAPITAL MANAGEMENT LIMITED PARTNERSHIP By: Bulldog Capital Management, Inc. General Partner By: /s/ Brandon L. Marion Brandon L. Marion President BULLDOG CAPITAL MANAGEMENT, INC. /s/ Ronald J. Pollack RONALD J. POLLACK By: /s/ Brandon L. Marion Brandon L. Marion President Page 10 of 10 -----END PRIVACY-ENHANCED MESSAGE-----